Director, Clinical Biomarker Compugen San Francisco, California, United States
Disclosure(s):
Yu Liang, PhD: No financial relationships to disclose
Learning Objectives:
Upon completion, participant will be able to distinguish the difference of using biomarkers for exploratory research and applying biomarkers into clinical trials.
Upon completion, participant will be able to demonstrate high-level strategies of clinical development of biomarkers.
Upon completion, participant will be able to understand the challenges of translating exploratory biomarkers into clinical trials.
